Study In Patients With Dyslipidaemia
NCT00264667
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
290
Enrollment
INDUSTRY
Sponsor class
Conditions
Metabolic Syndrome X
Interventions
DRUG:
GW677954
Sponsor
GlaxoSmithKline